Healthcare provider profile · identity verified

Ibrahim Seki, MD

Internal Medicine · VIDALIA, LA · NPI 1700922069

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	624	74
Gabapentin	Gabapentin	461	108
Pantoprazole Sodium	Pantoprazole Sodium	416	85
Alprazolam	Alprazolam	393	44
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	337	80
Amlodipine Besylate	Amlodipine Besylate	281	85
Potassium Chloride	Potassium Chloride	241	68
Atorvastatin Calcium	Atorvastatin Calcium	206	68
Metformin Hcl	Metformin Hcl	173	42
Glipizide Er	Glipizide	169	48
Tamsulosin Hcl	Tamsulosin Hcl	156	36
Azithromycin	Azithromycin	153	88
Januvia	Sitagliptin Phosphate	153	39
Albuterol Sulfate Hfa	Albuterol Sulfate	152	47
Furosemide	Furosemide	151	45
Omeprazole	Omeprazole	149	23
Quetiapine Fumarate	Quetiapine Fumarate	135	21
Amitriptyline Hcl	Amitriptyline Hcl	133	30
Tramadol Hcl	Tramadol Hcl	131	20
Trazodone Hcl	Trazodone Hcl	122	26
Rosuvastatin Calcium	Rosuvastatin Calcium	121	36
Levothyroxine Sodium	Levothyroxine Sodium	106	33
Metoprolol Tartrate	Metoprolol Tartrate	106	25
Celecoxib	Celecoxib	104	25
Clonazepam	Clonazepam	103	14
Finasteride	Finasteride	99	21
Baclofen	Baclofen	98	25
Hydroxyzine Hcl	Hydroxyzine Hcl	90	21
Lisinopril	Lisinopril	90	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	89	52
Clopidogrel	Clopidogrel Bisulfate	89	30
Prednisone	Prednisone	83	53
Oxybutynin Chloride Er	Oxybutynin Chloride	82	21
Carvedilol	Carvedilol	80	26
Alendronate Sodium	Alendronate Sodium	79	23
Hydrochlorothiazide	Hydrochlorothiazide	77	26
Metoprolol Succinate	Metoprolol Succinate	77	22
Valsartan	Valsartan	77	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	14
Losartan Potassium	Losartan Potassium	73	22
Pravastatin Sodium	Pravastatin Sodium	70	19
Duloxetine Hcl	Duloxetine Hcl	68	11
Zolpidem Tartrate	Zolpidem Tartrate	67	11
Allopurinol	Allopurinol	66	13
Olmesartan Medoxomil	Olmesartan Medoxomil	66	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	60	33
Escitalopram Oxalate	Escitalopram Oxalate	58	14
Linzess	Linaclotide	58	22
Nifedipine Er	Nifedipine	58	15
Clonidine Hcl	Clonidine Hcl	55	14
Buspirone Hcl	Buspirone Hcl	54	11
Fluoxetine Hcl	Fluoxetine Hcl	52	11
Labetalol Hcl	Labetalol Hcl	52	13
Benazepril Hcl	Benazepril Hcl	51	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	51	suppressed
Simvastatin	Simvastatin	51	12
Doxycycline Monohydrate	Doxycycline Monohydrate	50	36
Farxiga	Dapagliflozin Propanediol	49	16
Montelukast Sodium	Montelukast Sodium	49	15
Fluconazole	Fluconazole	48	18
Esomeprazole Magnesium	Esomeprazole Magnesium	47	suppressed
Famotidine	Famotidine	47	14
Sertraline Hcl	Sertraline Hcl	47	13
Ibuprofen	Ibuprofen	43	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Tizanidine Hcl	Tizanidine Hcl	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	43	23
Trulicity	Dulaglutide	43	suppressed
Methylprednisolone	Methylprednisolone	42	29
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	40	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	40	suppressed
Ondansetron Odt	Ondansetron	40	12
Amoxicillin	Amoxicillin	39	16
Eliquis	Apixaban	39	15
Fentanyl	Fentanyl	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	13
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	14
Meclizine Hcl	Meclizine Hcl	37	17
Lorazepam	Lorazepam	36	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	35	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Promethazine Hcl	Promethazine Hcl	35	suppressed
Propranolol Hcl Er	Propranolol Hcl	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	15
Sucralfate	Sucralfate	33	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	32	11
Lovastatin	Lovastatin	32	suppressed
Ozempic	Semaglutide	31	12
Clindamycin Hcl	Clindamycin Hcl	30	18
Methocarbamol	Methocarbamol	30	15
Temazepam	Temazepam	30	suppressed
Pregabalin	Pregabalin	28	suppressed
Sulindac	Sulindac	28	13
Jardiance	Empagliflozin	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Risperidone	Risperidone	26	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	25	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Torsemide	Torsemide	25	suppressed
Acarbose	Acarbose	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	11
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Naproxen	Naproxen	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Meloxicam	Meloxicam	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	20
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Indomethacin	Indomethacin	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Repaglinide	Repaglinide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Metronidazole	Metronidazole	19	17
Topiramate	Topiramate	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Atenolol	Atenolol	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Etodolac	Etodolac	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Probenecid	Probenecid	17	suppressed
Felodipine Er	Felodipine	16	suppressed
Levofloxacin	Levofloxacin	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Diazepam	Diazepam	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Proair Respiclick	Albuterol Sulfate	12	11
Tradjenta	Linagliptin	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Ibu	Ibuprofen	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	11
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error